Evidence map›Paper›PMID 33596947›Full record

ArticleGlobalization and health2021

Implementation science research for the scale-up of evidence-based interventions for sickle cell disease in africa: a commentary.

Joyce Gyamfi, Temitope Ojo, Juliet Iwelunmor, Gbenga Ogedegbe, Nessa Ryan, Amy Cohen, Obiageli Nnodu, Ambroise Wonkam, Charmaine Royal, Emmanuel Peprah

Open access · goldAbstract readLetter
In one paragraph

Article in Globalization and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Review
  3. Advances and Gaps in Global Newborn Screening for Sickle Cell Disease.International journal of neonatal screening · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Joyce GyamfiGlobal Health Program and Department of Social and Behavioral Sciences, NYU School of Global Public Health, 14 East 4th Street, 3rd Fl, New York, NY, 10003, USA. gyamfj01@nyu.edu.ORCID 0000-0001-5037-0833
Temitope OjoGlobal Health Program and Department of Social and Behavioral Sciences, NYU School of Global Public Health, 14 East 4th Street, 3rd Fl, New York, NY, 10003, USA.
Juliet IwelunmorBehavioral Science and Health Education, College for Public Health and Social Justice, Salus Center, Saint Louis University, 3545 Lafayette Avenue, Saint Louis, MO, 63103, USA.
Gbenga OgedegbeDepartment of Population Health, NYU School of Medicine, NYU Langone Health, 180 Madison Avenue,7th Fl, New York, NY, 10016, USA.
Nessa RyanGlobal Health Program and Department of Social and Behavioral Sciences, NYU School of Global Public Health, 14 East 4th Street, 3rd Fl, New York, NY, 10003, USA.
Amy CohenGlobal Health Program and Department of Social and Behavioral Sciences, NYU School of Global Public Health, 14 East 4th Street, 3rd Fl, New York, NY, 10003, USA.
Obiageli NnoduCentre of Excellence for Sickle Cell Disease Research & Training (CESRTA), University of Abuja, Airport - Giri Expressway, Abuja, Federal Capital Territory, Nigeria.
Ambroise WonkamDivision of Human Genetics, Faculty of Health Sciences - University of Cape Town, Anzio Road Observatory, Cape Town, 7925, South Africa.
Charmaine RoyalDepartments of African & African American Studies, Biology, Global Health, and Family Medicine & Community Health, Duke University, 1316 Campus Drive, 234 Ernestine Friedl Building, Box 90252, Durham, NC, 27708, USA.
Emmanuel PeprahGlobal Health Program and Department of Social and Behavioral Sciences, NYU School of Global Public Health, 14 East 4th Street, 3rd Fl, New York, NY, 10003, USA.
Duke University · USNew York University · USNYU Langone Health · USSaint Louis University · USUniversity of Abuja · NGUniversity of Cape Town · ZA

Funding

Sickle Africa Data Coordinating CenterU24HL135600 · NHLBI · UNIVERSITY OF CAPE TOWN · PI MULDER, NICOLA, WONKAM, AMBROISE · 2017 to 2025
$8.6M
NHLBI NIH HHS U24 HL135600
6 · The paper itself

Abstract

backgroundThe burden of sickle cell disease (SCD) is greatest among African nations. Effective scalability of evidence-based interventions (e.g., newborn screening, health education, prophylaxis for infection, optimal nutrition and hydration, hydroxyurea therapy, blood transfusions, and transcranial Doppler (TCD) screening) is urgently needed particularly in these settings for disease management. However, Africa is constrained by limited resources and the lack of capacity to conduct implementation science research for proper understanding of context, and assessment of barriers and facilitators to the uptake and scalability of evidence-based interventions (EBI) for SCD management. MAIN BODY: We outline implementation science approaches to embed EBI for SCD within the African context and highlight key implementation research programs for SCD management. Building implementation research capacity will meet the major need of developing effective life-long and accessible locally-tailored interventions for patients with SCD in Africa.

conclusionThis commentary communicates the importance of the application of implementation science methodology to scale-up evidence-based interventions for the management of SCD in order to reduce pain, prevent other morbidities and premature death experienced by people with SCD in Africa, and improve their overall quality of life.

Indexed as

Anemia, Sickle CellImplementation ScienceAfricaEvidence-Based MedicineHumansQuality of LifeAfricaGlobal healthImplementation science researchScale-upSickle cell disease

Identifiers

PMID33596947
PMCPMC7888072
OpenAlexW3130588642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.